Cita APA (7a ed.)

Minohara, K., Matoba, T., Kawakita, D., Takano, G., Oguri, K., Murashima, A., . . . Iwasaki, S. (2021). Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab. Nature Portfolio.

Cita Chicago Style (17a ed.)

Minohara, Kiyoshi, et al. Novel Prognostic Score for Recurrent or Metastatic Head and Neck Cancer Patients Treated with Nivolumab. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Minohara, Kiyoshi, et al. Novel Prognostic Score for Recurrent or Metastatic Head and Neck Cancer Patients Treated with Nivolumab. Nature Portfolio, 2021.